Iypoly
NDC Package 82462-103-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Iypoly is remove the protective cover and pump it a few times until it sprays evenly before the first use. Marketed by Whoniz, this product is identified by NDC 82462-103 and is authorized under FDA application part356.

Identification & Billing

NDC Package Code
82462-103-01
Package Description
20 mL in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
82462010301

Clinical Specifications

Proprietary Name
Iypoly
Dosage Form
-
Usage Information
Remove the protective cover and pump it a few times until it sprays evenly before the first use. Hold the body upright. Gently insert the tip of the device into the front part of the nose. Spray 1~2 times or required amount into the nose. After use, put the protective cover back on.

Regulatory & Marketing

Labeler Name
Whoniz
FDA Application #
part356
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
12-23-2021
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82462-103-01 identifies a specific commercial package of 20 ml in 1 bottle, spray of Iypoly, labeled by Whoniz. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Whoniz on December 23, 2021. The current certification is valid through December 31, 2023.

How is this Whoniz product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82462010301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82462-103-01
11-Digit CMS (5-4-2)
82462-0103-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.